Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats

European Journal of Pharmacology

Volumn 648, Issue 1-3, 2010, Pages 102-109

  Jaggi, Amteshwar Singh ^a   Singh, Nirmal ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Chronic constriction injury; Inflammation; Sciatic nerve ligation; Spironolactone; Vincristine

Indexed keywords

ACETONE; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE SULFATE;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; FEMALE; FOOT MALFORMATION; HOT PLATE TEST; HYPERALGESIA; MALE; NERVE COMPRESSION; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; PRICK TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RAT; SCIATIC NERVE; TREATMENT DURATION;

ANIMALS; CONSTRICTION; FEMALE; FOOT DEFORMITIES; HYPERALGESIA; MALE; NEURALGIA; RATS; RATS, WISTAR; SPIRONOLACTONE; TUMOR NECROSIS FACTOR-ALPHA; VINCRISTINE;

EID: 77957753743     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.08.050     Document Type: Article

References (53)

1. Abdel-Salam O.M.E., Baiuomy A.R., Nada S.A. Effect of spironolactone on pain responses in mice. EXCLI J. 2010, 9:46-57.
2. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
3. Bromberg M.B. Peripheral neurotoxic disorders. Clin. Neurobehav. Toxicol. 2000, 18:681-689.
4. Campana C., Alessandrino G., Striuli L., Agnesina L., Dequarti M.C., Ghio S., Scelsi L., Tavazzi L. The tailored medical therapy in patients with advanced heart failure referred for cardiac transplantation. Transplant. Proc. 2008, 40:1999-2000.
5. Doggrell S.A., Brown L. The spironolactone renaissance. Expert Opin. Investig. Drugs 2001, 10:943-954.
6. Dowdall T., Robinson I., Meert T.F. Comparison of five different rat models of peripheral nerve injury. Pharmacol. Biochem. Behav. 2005, 80:93-108.
7. Dworkin R.H. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin. J. Pain 2002, 18:343-349.
8. Empl M., Renaud S., Erne B., Fuhr P., Straube A., Schaeren-Wiemers N., Steck A.J. TNF-alpha expression in painful and nonpainful neuropathies. Neurology 2001, 56:1371-1377.
9. Erichsen H.K., Blackburn-Munro G. Pharmacological characterization of the spared nerve injury model of neuropathic pain. Pain 2002, 98:151-161.
10. Flatters S.J., Bennett G.J. Ethosuximide reverses paclitaxel- and vincritine-induced painful peripheral neuropathy. Pain 2004, 109:150-161.
11. Gracely R.H., Lynch S.A., Bennett G.J. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992, 51:175-194.
12. Harden N., Cohen M. Unmet needs in the management of neuropathic pain. J. Pain Symptom Manage. 2003, 25:S12-S17.
13. Ikeda H., Tsuruya K., Toyonaga J., Masutani K., Hayashida H., Hirakata H., Iida M. Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats. Kidney Int. 2009, 75:147-155.
14. Jaffe I.Z., Mendelsohn M.E. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ. Res. 2005, 96:643-650.
15. Jaggi A.S., Jain V., Singh N. Animal models of neuropathic pain. Fundam. Clin. Pharmacol. 2009, Dec 17 [Epub ahead of print].
16. Jain V., Jaggi A.S., Singh N. Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats. Pharmacol. Res. 2009, 59:385-392.
17. Jancálek R., Dubovỳ P., Svízenská I., Klusáková I. Bilateral changes of TNF-alpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerve. J. Neuroinflammation 2010, 7:11.
18. Jiang Y.Q., Xing G.G., Wang S.L., Tu H.Y., Chi Y.N., Li J., Liu F.Y., Han J.S., Wan Y. Axonal accumulation of hyperpolarization-activated cyclic nucleotide-gated cation channels contributes to mechanical allodynia after peripheral nerve injury in rat. Pain 2008, 137:495-506.
19. Jin Y., Sato J., Yamazaki M., Omura S., Funakubo M., Senoo S., Aoyama M., Mizumura K. Changes in cardiovascular parameters and plasma norepinephrine level in rats after chronic constriction injury on the sciatic nerve. Pain 2008, 135:221-231.
20. Kang Y.M., Zhang Z.H., Johnson R.F., Yu Y., Beltz T., Johnson A.K., Weiss R.M., Felder R.B. Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure. Circ. Res. 2006, 99:758-766.
21. Kaur G., Jaggi A.S., Singh N. Exploring the potential effect of Ocimum sanctum in vincristine-induced neuropathic pain in rats. J. Brachial Plex. Peripher. Nerve Inj. 2010, 5:3.
22. Khan N., Bakshi K.S., Jaggi A.S., Singh N. Ameliorative potential of spironolactone in diabetes induced hyperalgesia in mice. Yakugaku Zasshi 2009, 129:593-599.
23. Kiguchi N., Maeda T., Kobayashi Y., Kishioka S. Up-regulation of tumor necrosis factor-alpha in spinal cord contributes to vincristine-induced mechanical allodynia in mice. Neurosci. Lett. 2008, 445:140-143.
24. Kiguchi N., Maeda T., Kobayashi Y., Kondo T., Ozaki M., Kishioka S. The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice. Eur. J. Pharmacol. 2008, 592:87-92.
25. Kim K.J., Yoon Y.W., Chung J.M. Comparison of three rodent neuropathic pain models. Exp. Brain Res. 1997, 113:200-206.
26. Kithas P.A., Supiano M.A. Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension. J. Am. Geriatr. Soc. 2010, 58:1327-1332.
27. Leung L., Cahill C.M. TNF-alpha and neuropathic pain-a review. J. Neuroinflammation 2010, 7:27.
28. Lin S., Li D., Jia J., Zheng Z., Jia Z., Shang W. Spironolactone ameliorates podocytic adhesive capacity via restoring integrin {alpha} 3 expression in streptozotocin-induced diabetic rats. J. Renin Angiotensin Aldosterone Syst. 2010, 11:149-157.
29. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
30. Marian A.J. Experimental therapies in hypertrophic cardiomyopathy. J. Cardiovasc. Transl. Res. 2009, 2:483-492.
31. Maves T.J., Pechman P.S., Gebhart G.F., Meller S.T. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain 1993, 54:57-69.
32. Miura R., Nakamura K., Miura D., Miura A., Hisamatsu K., Kajiya M., Nagase S., Morita H., Fukushima K.K., Ohe T., Ishihara K. Anti-inflammatory effect of spironolactone on human peripheral blood mononuclear cells. J. Pharmacol. Sci. 2006, 101:256-259.
33. Muthuraman A., Jaggi A.S., Singh N., Singh D. Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats. Eur. J. Pharm. 2008, 587:104-111.
34. Nakazato-Imasato E., Kurebayashi Y. Pharmacological characteristics of the hind paw weight bearing difference induced by chronic constriction injury of the sciatic nerve in rats. Life Sci. 2009, 84:622-626.
35. Ochoa J.L., Yarnitsky D. Mechanical hyperalgesias in neuropathic pain patients: dynamic and static subtypes. Ann. Neurol. 1993, 33:465-472.
36. Paccola C.C., Gutierrez V.P., Longo I., Juliano L., Juliano M.A., Giorgi R. Antinociceptive effect of the C-terminus of murine S100A9 protein on experimental neuropathic pain. Peptides 2008, 29:1806-1814.
37. Rude M.K., Duhaney T.A., Kuster G.M., Judge S., Heo J., Colucci W.S., Siwik D.A., Sam F. Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes. Hypertension 2005, 46:555-561.
38. Sacerdote P., Franchi S., Trovato A.E., Valsecchi A.E., Panerai A.E., Colleoni M. Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Neurosci. Lett. 2008, 436:210-213.
39. Siau C., Bennett G.J. Dysregulation of neuronal calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth. Analg. 2006, 102:1485-1490.
40. Sommer C., Schäfers M. Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res. 1998, 784:154-162.
41. Sommer C., Lindenlaub T., Teuteberg P., Schafers M., Hartung T., Toyka K.V. Anti-TNF-neutralizing antibodies reduce pain-related behaviour in two different mouse models of painful mononeuropathy. Brain Res. 2001, 913:86-89.
42. Sønder S.U., Mikkelsen M., Rieneck K., Hedegaard C.J., Bendtzen K. Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction. Br. J. Pharmacol. 2006, 148:46-53.
43. Sønder S.U., Woetmann A., Odum N., Bendtzen K. Spironolactone induces apoptosis and inhibits NF-kappaB independent of the mineralocorticoid receptor. Apoptosis 2006, 11:2159-2165.
44. Sorkin L.S., Doom C.M. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat. J. Peripher. Nerv. Syst. 2000, 5:96-100.
45. Sun Y., Zhang J., Lu L., Chen S.S., Quinn M.T., Weber K.T. Aldosterone induced inflammation in the rat heart: role of oxidative stress. Am. J. Pathol. 2002, 161:1773-1781.
46. Syngle A., Vohra K., Kaur L., Sharma S. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis. Scand. J. Rheumatol. 2009, 38:15-22.
47. Thacker M.A., Clark A.K., Marchand F., McMahon S.B. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth. Analg. 2007, 105:838-847.
48. Thibault K., Elisabeth B., Sophie D., Claude F.Z., Bernard R., Bernard C. Antinociceptive and anti-allodynic effects of oral PL37, a complete inhibitor of enkephalin-catabolizing enzymes, in a rat model of peripheral neuropathic pain induced by vincristine. Eur. J. Pharmacol. 2008, 600:71-77.
49. Uzunhasan I., Yildiz A., Coskun U., Kalyoncuoglu M., Baskurt M., Cakar M.A., Kaya A., Pehlivanoglu S., Enar R., Okcun B. Effects of aldosterone blockade on left ventricular function and clinical status during acute myocardial infarction. Scand. J. Clin. Lab. Investig. 2009, 69:545-549.
50. Wagner R., Myers R.R. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 1996, 73:625-629.
51. Weissman-Fogel I., Dashkovsky A., Rogowski Z., Yarnitsky D. Vagal damage enhances polyneuropathy pain: additive effect of two algogenic mechanisms. Pain 2008, 138:153-162.
52. Wilkinson-Berka J.L., Tan G., Jaworski K., Miller A.G. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Circ. Res. 2009, 104:124-133.
53. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.